Indication
Treatment of essential hypertension. Treatment of renal disease in patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen.
Loading your page…
Loading your page…
Hypertension
Marketing Authorisation Holder: Krka, d.d., Novo mesto
EMA Authorisation: 01/12/2008
INN: irbesartan
AI Drug & Interaction Analysis
Free account required
Ask Osler about Ifirmasta (previously Irbesartan Krka): drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.